These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 34127070)

  • 21. Interaction of gut microbiota with bile acid metabolism and its influence on disease states.
    Staley C; Weingarden AR; Khoruts A; Sadowsky MJ
    Appl Microbiol Biotechnol; 2017 Jan; 101(1):47-64. PubMed ID: 27888332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Gut Microbiota-Mediated Bile Acid Metabolism on the Solubilization Capacity of Bile Salt Micelles and Drug Solubility.
    Enright EF; Joyce SA; Gahan CG; Griffin BT
    Mol Pharm; 2017 Apr; 14(4):1251-1263. PubMed ID: 28186768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baat Gene Knockout Alters Post-Natal Development, the Gut Microbiome, and Reveals Unusual Bile Acids in Mice.
    Neugebauer KA; Okros M; Guzior DV; Feiner J; Chargo NJ; Rzepka M; Schilmiller AL; O'Reilly S; Jones AD; Watson VE; Luyendyk JP; McCabe LR; Quinn RA
    J Lipid Res; 2022 Dec; 63(12):100297. PubMed ID: 36243101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut-microbiota derived bioactive metabolites and their functions in host physiology.
    Debnath N; Kumar R; Kumar A; Mehta PK; Yadav AK
    Biotechnol Genet Eng Rev; 2021 Oct; 37(2):105-153. PubMed ID: 34678130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
    Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
    Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholestasis impairs gut microbiota development and bile salt hydrolase activity in preterm neonates.
    Lynch LE; Hair AB; Soni KG; Yang H; Gollins LA; Narvaez-Rivas M; Setchell KDR; Preidis GA
    Gut Microbes; 2023; 15(1):2183690. PubMed ID: 36843227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BaiJ and BaiB are key enzymes in the chenodeoxycholic acid 7α-dehydroxylation pathway in the gut microbe
    Meibom KL; Marion S; Volet C; Nass T; Vico-Oton E; Menin L; Bernier-Latmani R
    Gut Microbes; 2024; 16(1):2323233. PubMed ID: 38465624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Hylemon-Björkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology.
    Ridlon JM; Daniel SL; Gaskins HR
    J Lipid Res; 2023 Aug; 64(8):100392. PubMed ID: 37211250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The gut microbial influence on cholestatic liver disease.
    Kummen M; Hov JR
    Liver Int; 2019 Jul; 39(7):1186-1196. PubMed ID: 31125502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between Bile Acids and Gut Microbiota and Its Impact on Farnesoid X Receptor Signalling.
    Wahlström A; Kovatcheva-Datchary P; Ståhlman M; Bäckhed F; Marschall HU
    Dig Dis; 2017; 35(3):246-250. PubMed ID: 28249261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascular Disease.
    Rodríguez-Morató J; Matthan NR
    Curr Atheroscler Rep; 2020 Jul; 22(9):47. PubMed ID: 32681421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbial impact on cholesterol and bile acid metabolism: current status and future prospects.
    Kriaa A; Bourgin M; Potiron A; Mkaouar H; Jablaoui A; Gérard P; Maguin E; Rhimi M
    J Lipid Res; 2019 Feb; 60(2):323-332. PubMed ID: 30487175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota from coronary artery disease patients contributes to vascular dysfunction in mice by regulating bile acid metabolism and immune activation.
    Liu H; Tian R; Wang H; Feng S; Li H; Xiao Y; Luan X; Zhang Z; Shi N; Niu H; Zhang S
    J Transl Med; 2020 Oct; 18(1):382. PubMed ID: 33036625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bile Acids: Key Players in Inflammatory Bowel Diseases?
    Kriaa A; Mariaule V; Jablaoui A; Rhimi S; Mkaouar H; Hernandez J; Korkmaz B; Lesner A; Maguin E; Aghdassi A; Rhimi M
    Cells; 2022 Mar; 11(5):. PubMed ID: 35269523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between Diet, Bile Acid Metabolism, Gut Microbiota, and Inflammatory Bowel Diseases.
    Devkota S; Chang EB
    Dig Dis; 2015; 33(3):351-6. PubMed ID: 26045269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consequences of bile salt biotransformations by intestinal bacteria.
    Ridlon JM; Harris SC; Bhowmik S; Kang DJ; Hylemon PB
    Gut Microbes; 2016; 7(1):22-39. PubMed ID: 26939849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BSH-TRAP: Bile salt hydrolase tagging and retrieval with activity-based probes.
    Parasar B; Chang PV
    Methods Enzymol; 2022; 664():85-102. PubMed ID: 35331380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease.
    Long XQ; Liu MZ; Liu ZH; Xia LZ; Lu SP; Xu XP; Wu MH
    World J Gastroenterol; 2023 Jul; 29(27):4252-4270. PubMed ID: 37545642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternating Dual-Collision Energy Scanning Mass Spectrometry Approach: Discovery of Novel Microbial Bile-Acid Conjugates.
    Zhu QF; Wang YZ; An N; Hao JD; Mei PC; Bai YL; Hu YN; Bai PR; Feng YQ
    Anal Chem; 2022 Feb; 94(5):2655-2664. PubMed ID: 35085440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.